More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Kannalife™ Sciences Spokesman Nick Lowery Discusses CTE with Denver’s Mile High Sports Radio

Kannalife™ Sciences Spokesman Nick Lowery Discusses CTE with Denver’s Mile High Sports Radio

by adminAdrianRamirez | Nov 5, 2017 | Media Coverage

Ahead of last Monday night’s Broncos-Chiefs game, Kannalife™ Sciences spokesman and former NFL player Nick Lowery joined Denver’s Mile High Sports Radio show to share his thoughts on the game and explain the work that Kannalife™ is doing around oxidative brain...
Medical Marijuana, Inc. Subsidiary Kannaway® to Hold Its Evolution National Convention in Denver, CO November 4-5, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® to Hold Its Evolution National Convention in Denver, CO November 4-5, 2017

by adminAdrianRamirez | Nov 3, 2017 | Kannaway, Press Releases

SAN DIEGO, Nov. 3, 2017 /PRNewswire/ — Medical Marijuana, Inc.(OTC:MJNA) announced today that subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding the Kannaway 2017 Evolution National Convention...
Medical Marijuana, Inc. Announces Prominent Coverage on Mexican News Station About Benefits of CBD and Global CBD Policy

Medical Marijuana, Inc. Announces Prominent Coverage on Mexican News Station About Benefits of CBD and Global CBD Policy

by adminAdrianRamirez | Nov 2, 2017 | HempMeds Mexico, Press Releases

SAN DIEGO, Nov. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, General Manager of subsidiary HempMeds® Mexico, was recently interviewed on Azteca...
Raul Elizalde Interviewed by Azteca TV in Lead-up to W.H.O. Presentation

Raul Elizalde Interviewed by Azteca TV in Lead-up to W.H.O. Presentation

by adminAdrianRamirez | Nov 2, 2017 | Media Coverage, RaulWHO

Days before addressing the United Nations, medical cannabis advocate and the head of HempMeds® Mexico discussed CBD with Azteca TV. https://www.medicalmarijuanainc.com/wp-content/uploads/2017/11/Beneficios-del-uso-medicinal-de-la-marihuana-con-Raúl-Elizalde.mp4 Raúl...
Medical Marijuana, Inc.’s Expanding Global Reach Featured in MMJ Reporter

Medical Marijuana, Inc.’s Expanding Global Reach Featured in MMJ Reporter

by adminAdrianRamirez | Nov 2, 2017 | Media Coverage

Online article focuses on MJNA’s international subsidiaries and the company’s role in bringing CBD oil products to the world. Medical Marijuana, Inc. and its portfolio of companies were a central part of a recent article published on MMJ Reporter exploring the...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.